Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 3/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | MGAM | O43451 | 1/20 | 0.30 |
| ▸ | SI | P14410 | 1/20 | 0.30 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27993329 | 0.83 | MGAM (0.36) | TSHRGAAHSD17B10ALDH1A1MAPT | |
| SCHEMBL28615436 | 0.81 | — | — | |
| SCHEMBL905316 | 0.81 | CYP1A2 (0.33) | — | |
| SCHEMBL3683069 | 0.81 | TSHR (0.35) | TSHREGFRGAAHSD17B10HTT | |
| SCHEMBL11507777 | 0.81 | TSHR (0.35) | TSHREGFRGAAHSD17B10HTT | |
| SCHEMBL9367097 | 0.78 | — | — | |
| SCHEMBL27671098 | 0.74 | — | — | |
| SCHEMBL5379373 | 0.73 | EPHX2 (0.35) | GAALMNAKMT2A | |
| SCHEMBL28624166 | 0.72 | — | — | |
| SCHEMBL31512459 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113072504-B | Chemical synthesis method of bosentan metabolite | 四川摩尔生物制药有限公司 | 2022-11-22 | — | — | CN | claimed |
| CN-113072504-A | Chemical synthesis method of bosentan metabolite | 四川摩尔生物制药有限公司 | 2021-07-06 | — | — | CN | claimed |
| US-12494506-B2 | Nonaqueous electrolytic solution and energy device including the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-12-09 | — | — | US | disclosed |
| EP-3780227-B1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND ENERGY DEVICE INCLUDING THE SAME | MITSUBISHI CHEM CORP (JP) | 2024-07-24 | — | — | EP | disclosed |
| CN-111801833-B | Nonaqueous electrolyte and energy device using same | 三菱化学株式会社 | 2024-07-16 | — | — | CN | disclosed |
| CN-111788733-B | Nonaqueous electrolyte and power storage device using same | 三菱化学株式会社 | 2024-02-02 | — | — | CN | disclosed |
| CN-113072504-B | Chemical synthesis method of bosentan metabolite | 四川摩尔生物制药有限公司 | 2022-11-22 | — | — | CN | disclosed |
| CN-113072504-B | Chemical synthesis method of bosentan metabolite | 四川摩尔生物制药有限公司 | 2022-11-22 | — | — | CN | disclosed |
| CN-113979960-B | Preparation method of bilastine intermediate | 南京桦冠生物技术有限公司 | 2022-03-18 | — | — | CN | disclosed |
| CN-113979960-A | Preparation method of bilastine intermediate | 南京桦冠生物技术有限公司 | 2022-01-28 | — | — | CN | disclosed |
| CN-113072504-A | Chemical synthesis method of bosentan metabolite | 四川摩尔生物制药有限公司 | 2021-07-06 | — | — | CN | disclosed |
| CN-113072504-A | Chemical synthesis method of bosentan metabolite | 四川摩尔生物制药有限公司 | 2021-07-06 | — | — | CN | disclosed |
| EP-3780227-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ENERGY DEVICE USING SAME | Mitsubishi Chemical Corporation (JP) | 2021-02-17 | — | — | EP | disclosed |
| US-20200388884-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND ENERGY DEVICE INCLUDING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-12-10 | — | — | US | disclosed |
| CN-106415910-B | Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery using same | 三菱化学株式会社 | 2019-05-03 | — | — | CN | disclosed |
| CN-106415910-A | Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery using same | 三菱化学株式会社 | 2017-02-15 | — | — | CN | disclosed |